Fundraising Fox

Manus Bio

Augusta, US · Delaware corporation · 9 known investors

manusbio.com ↗

Manus develops and manufactures bioalternatives—sustainable ingredients produced using engineered microbes and cell factories—for use in food, flavor, fragrance, and other consumer products. The company offers an end-to-end scale-up platform spanning cell factory design, engineering, and biomanufacturing.

BiotechCleantechin /manus@manusbio

Founders & leadership

RG
Richard GoldsteinDirector
JW
Jason WhaleyDirector
CB
Carsten BoersDirector
AP
Ajikumar ParayilExecutive Officer, Director
GS
Gregory StephanopoulosDirector

Investors · 9

+ND CapitalWoodside · $540K – $5.4M
Civilization Ventures Management, LlcTiburon · $1M – $10M
Energy Impact PartnersNew York · $5M – $20M
Liebenthal VenturesOld Westbury · $25K – $500K
Nelstone Venturesvia Rich Nelson · inferred
NXT VenturesMarblehead · $250K – $1M
Prefix CapitalSan Francisco
Rhapsody Venture PartnersCambridge · $500K – $2M
Alpha Wave GlobalreportedMiamivia Rick Gerson · board

Reported raises · per SEC filings

Form D private placements
▶$11.3MraisedMay 2024 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Ajikumar Parayil KumaranDirector, Executive Officer
  • Rick GersonDirector
  • Alena IvashenkaDirector
  • Julio A. Ruiz CalderonExecutive Officer
  • Michael CarlosDirector
  • Jean NehmeDirector
Offering amount
$11.3M
Amount sold
$11.3M
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21.2MraisedMay 2023 · 14 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • John NehmeDirector
  • Michael CarlosDirector
  • Jeremiah HuxExecutive Officer
  • Ajikumar ParayilExecutive Officer, Director
  • Rick GersonDirector
  • Alena IvashenkaDirector
Offering amount
$22.3M
Amount sold
$21.2M
First sale
Aug 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$66.2MraisedNov 2020 · 27 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory StephanopoulosDirector
  • Zanna McFersonDirector
  • Raymond ChangDirector
  • Bryon AlsbergDirector
  • Michael CarlosDirector
  • Colin GoundenDirector
  • Christine SantosExecutive Officer
  • Paul BoniExecutive Officer
  • Jeff AndersonExecutive Officer
  • Ajikumar ParayilExecutive Officer, Director
Offering amount
$80M
Amount sold
$66.2M
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedJul 2018 · 15 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul BoniExecutive Officer
  • Zanna McFersonDirector
  • Michael CarlosDirector
  • Gregory StephanopoulosDirector
  • Colin GoundenDirector
  • Raymond ChangDirector
  • Ajikumar ParayilExecutive Officer, Director
  • Bryon AlsbergDirector
  • Christine SantosExecutive Officer
  • Jeff AndersonExecutive Officer
Offering amount
$12M
Amount sold
$10M
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.1MraisedDec 2017 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Byron AlsbergDirector
  • Michael CarlosDirector
  • Colin GoundenDirector
  • Carsten BoersDirector
  • Gregory StephanopoulosDirector
  • Ajikumar ParayilExecutive Officer, Director
Offering amount
$10M
Amount sold
$9.1M
First sale
Aug 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedOct 2016 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard GoldsteinDirector
  • Jason WhaleyDirector
  • Carsten BoersDirector
  • Ajikumar ParayilExecutive Officer, Director
  • Gregory StephanopoulosDirector
Offering amount
$3M
Amount sold
$300K
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.